IVOL White Paper
By Nancy Davis CIO of Quadratic Capital
Please Register to Download this Report
For financial intermediary use only - not for retail distribution.
The latest news and research from our partners. Subscribe to our mailing list for more.
November 7, 2022 – Nancy Davis Tells HedgeEye’s Keith McCullough How IVOL is Different Than TIPS
November 7, 2022 – WSJ Features IVOL: Investors May Be Too Confident Rate Hikes Will Work
October 19, 2022 – KMLM & Managed Futures FAQ
October 19, 2022 – KMLM Sees Strong Performance Continue Amidst Global Market Strain in Q3
KFA Funds is a premier platform for developing and delivering differentiated, high-conviction investment strategies to global investors. Our newsletter is a collaboration between our internal research department and our distinguished partners. Together we strive to offer differentiated perspectives on high-conviction investment strategies and themes.
280 Park Avenue, 32nd Floor
New York, NY 10017
1 Embarcadero Center, Suite 2350
San Francisco, CA 94111
For financial intermediary use only - not for retail distribution.
Rising interest rates can hurt the value of fixed income securities. Additionally, inflation can erode the purchasing power of the fixed payments of bonds. IVOL provides:
* Based on Bloomberg reporting as of 5/8/2019, IVOL was the only US derivative based ETF to utilize OTC interest rate volatility options.
Hyperlinks on this website are provided as a convenience and we disclaim any responsibility for information, services or products found on the websites linked hereto.
Click here to continueYou are now leaving KFAFunds.com. Hyperlinks on these websites are provided as a convenience and we disclaim any responsibility for information, services or products found on the websites linked hereto.
This website uses cookies to help us enhance your browsing experience. By using this website you consent to our use of these cookies. To find out more about how we use cookies and how to manage them, please see our Terms & Conditions and Privacy Policy.